Of the estimated 37 million Americans who have diabetes (1), 90–95% have type 2 diabetes (2). An additional 96 million adults have prediabetes, which may progress to type 2 diabetes (1). Comorbidities of uncontrolled diabetes, which include obesity, microvascular complications (e.g., retinopathy, nephropathy, and neuropathy), and macrovascular complications (e.g., atherosclerotic cardiovascular disease [ASCVD], such as myocardial infarction or stroke) (2), warrant concern. Nearly 90% of patients with type 2 diabetes have overweight or obesity (3). Chronic kidney disease (CKD) affects 33–40% of these patients (4,5), and the risk of heart disease or stroke is doubled in patients with type 2 diabetes compared with those without diabetes (6). Cardiovascular mortality increases 1.15-fold for every 1% increase of A1C (7–9). A1C lowering has been proven to reduce the risk of these complications (10–13...

You do not currently have access to this content.